Tobramycin Injection, Solution
Product Images NDC 63323-305

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 63323-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Tobramycin (Tob0b 0000 01)

Chemical structure of Tobramycin sulfate, showing three linked sugar moieties with amino and hydroxyl groups.*

FDA Label Image

Figure (Tob0b 0000 02)

A reduced dosage nomogram chart for Tobramycin Injection, Solution showing the relationship between serum creatinine (mg/100 mL) on the x-axis and percent of normal dosage from Table 3 on the y-axis. The graph illustrates dosage adjustment based on creatinine clearance (mL/min/1.73 m²) from 0 to 70.*

FDA Label Image

Fresenius Kabi Logo (Tob0b 0000 03)

FDA Label Image

Vial (Tob0b 0000 04)

Label for Tobramycin Injection, USP Pediatric, 20 mg per 2 mL (10 mg/mL) multiple dose vial by Fresenius Kabi USA, LLC. This 2 mL solution is indicated for IM or IV use and must be diluted before use. The label includes the product NDC 63323-305-01 and a barcode.*

FDA Label Image

Tray (Tob0b 0000 05)

Tobramycin Injection, USP Pediatric 20 mg per 2 mL (10 mg per mL) solution for injection. The label indicates use for intramuscular or intravenous administration, requiring dilution before IV use. Pack contains 25 multiple dose vials of 2 mL each. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and active ingredient details included.*

FDA Label Image

1200 (Tob0b 0000 06)

Label for Tobramycin Injection, USP, 40 mg/mL (1,200 mg per 30 mL vial) by Fresenius Kabi USA, LLC. The label states intramuscular or intravenous use, dilution required before intravenous use, and storage instructions at controlled room temperature. It includes ingredient details and a barcode.*

FDA Label Image

Package Label – Principal Display – Tobramycin 2 mL Multiple Dose Vial Label (Tob0b 0000 07)

Label for Tobramycin Injection, U.S. prescription drug by Fresenius Kabi USA, LLC. It shows a concentration of 80 mg per 2 mL (40 mg per mL) in a multiple dose vial. Instructions note the injection is for intramuscular or intravenous use and must be diluted before administration.*

FDA Label Image

Package Label – Principal Display – Tobramycin 2 mL Multiple Dose Tray Label (Tob0b 0000 08)

Label for Tobramycin Injection, USP 80 mg per 2 mL (40 mg per mL) by Fresenius Kabi USA, LLC, in multiple dose vials of 25 x 2 mL. For intramuscular or intravenous use, requiring dilution before IV use. The label includes storage instructions and a list of inactive ingredients.*

FDA Label Image

Package Label – Principal Display – Tobramycin 30 mL Multiple Dose Tray Label (Tob0b 0000 09)

Label for Tobramycin Injection, USP 1,200 mg per 30 mL (40 mg per mL) solution for injection. The label states use is for intramuscular or intravenous routes, with a note that the product must be diluted before intravenous use. It comes in multiple dose vials, 10 vials per package, and is labeled Rx only. Manufacturer is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.